Viewing Study NCT02348957


Ignite Creation Date: 2025-12-24 @ 6:55 PM
Ignite Modification Date: 2026-01-25 @ 9:58 AM
Study NCT ID: NCT02348957
Status: COMPLETED
Last Update Posted: 2019-07-25
First Post: 2014-12-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Treating Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) With Dasatinib
Sponsor: Onco Medical Consult GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module